Lauren Gravitz is a freelance writer and editor in Hershey, Pennsylvania, who covers health, medicine, science and the environment. Her stories have appeared in Nature, Aeon, The Economist, Technology Review, O, The Oprah Magazine and Discover, among others.
Lauren Gravitz
Freelance Writer
From this contributor
A brief history of precision self-scanning
When a researcher solved a logistical problem by going rogue, the idea proved remarkably infectious.
A brief history of precision self-scanning
By
Lauren Gravitz
21 January 2026 | 13 min read
At the intersection of autism and trauma
Autism and post-traumatic stress disorder share many traits, but the connection between them was largely overlooked until now.
Autism’s drug problem
Many people on the spectrum take multiple medications — which can lead to serious side effects and may not even be effective.
Lack of DNA modification creates hotspots for mutations
The absence of a chemical alteration called methylation on some stretches of DNA makes them especially prone to mutations, according to a paper published in PLoS Genetics in May.
Lack of DNA modification creates hotspots for mutations
By
Lauren Gravitz
28 June 2012 | 4 min read
Explore more from The Transmitter
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
By
Lauren Schneider
4 February 2026 | 7 min read
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
By
Claudia López Lloreda
3 February 2026 | 4 min read
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
By
Calli McMurray
3 February 2026 | 5 min read